Peripheral blood natural killer cells in sarcoidosis are associated with early cardiac involvement

Eur J Clin Invest. 2022 May;52(5):e13742. doi: 10.1111/eci.13742. Epub 2022 Jan 17.

Abstract

Aim: To evaluate the distribution of circulating immune cell subsets in peripheral blood of patients with sarcoidosis and investigate if there is an association with an underlying cardiac involvement.

Methods and results: Eighty-five newly diagnosed treatment-naïve patients with sarcoidosis (50 women) were included in the study. All patients underwent a thorough cardiac investigation, including cardiac magnetic resonance imaging (CMR). Of all patients, 19 (23.53%) had myocardial involvement, and the NK subpopulation in these patients in peripheral blood was significantly decreased compared to patients without (n = 63, p = 0.001 and p = 0.003 respectively). The absolute number of NKT cells (CD3+CD16/56+ ) in patients with cardiac involvement was highly correlated with T2 map increased values in MRI (r = -686, p = 0.041) showing that low NKT cell count correlates with the inflammatory process of the heart. No difference in CD19, CD3, CD4, CD8 and CD3- NK cell counts was found between groups. Lung severity was not found to correlate with the number of NK cells.

Conclusion: We found that low NK cell count in peripheral blood of patients with sarcoidosis is associated with cardiac involvement, and the number of NK-T cells correlates with CMR findings indicative of myocardial inflammation. This finding might have a potential clinical application in detecting clinically silent cardiac involvement in sarcoidosis and may also suggest potential targets for therapeutic interventions.

Keywords: NK T cells; NK cells; cardiac magnetic resonance imaging; cardiac sarcoidosis; immunophenotype.

MeSH terms

  • Female
  • Flow Cytometry
  • Humans
  • Killer Cells, Natural* / pathology
  • Sarcoidosis* / pathology